Sciensano

Belgium Founded: 2018 • Age: 8 yrs
Health data analysis and public health monitoring are conducted.

About Sciensano

Sciensano is an Education company based in Belgium founded in 2018. Health data analysis and public health monitoring are conducted. Its website sciensano.be draws about 256 thousand monthly visits. Its focus areas include Healthcare and Medical Schools.

Company details

Sciensano was established in 2018 in Belgium within the public health sector. Health and disease surveillance is performed, alongside evaluations of vaccine safety and medical products. Food safety analysis and environmental health monitoring are undertaken. Services encompass data collection, quality assessments for external entities, research on health threats, and policy support through published reports. Surveillance networks are maintained across various domains.

  • Headquarters Belgium
  • Sectors
    Education
  • Website category Health · Biotechnology and Pharmaceuticals
  • Website sciensano.be
  • Social LinkedIn X
Key Metrics

Funding Insights of Sciensano

  • Total Rounds 18
  • Last Round Grant β€” $107,098
  • First Round $575,322

    (Jan 2018)

  • Investors Count 1

Latest 10 of 18 funding rounds of Sciensano with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2022$107,098Grant––
Nov 2021$589,519Grant––
Oct 2021$533,425Grant––
Jun 2021$23,383Grant––
Apr 2021$921,069Grant––
Mar 2021$288,261Grant––
Feb 2021$435,519Grant––
Feb 2020$168,540Grant––
Jan 2020$10.21MGrant––
Dec 2019$330,572Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in Sciensano

Sciensano has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for Sciensano

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Sciensano

37 people are tracked at Sciensano (9 in leadership, 28 in team).

NameRoleGroup
Herman van Oyen
Scientific Director Epidemiology And Public HealthLeadership
Wim de Clercq
Director Buildings, Infrastructure And Facilities And Member Of CodirLeadership
Fatima Amghar
Human Resources Director A.iLeadership
Birgit Mertens
Head Of Service Risk And Health Impact AssessmentLeadership
Nienke Schutte
Head Of Unit - EU Health Information SystemLeadership
Baudouin Durieux
Financial DirectorLeadership
Wesley van Dessel
Head Of CommunicationsLeadership
Christian Léonard
General managerLeadership
Brecht Devleesschauwer
Head Of Service, Health InformationLeadership
Niels Boschmans
Lab ExpertTeam
Johan van der Heyden
Senior ResearcherTeam
Léo Taquet
Information Technology Network EngineerTeam
Bart Desmedt
ScientistTeam
Redouane Talib
Expert En Informatique .net TechnologiesTeam
Marie-Sophie Croenne
Budget And Management ControllingTeam
Federica Rossetti
ScientistTeam
Raphael Janssens
Data ScientistTeam
Daisy Tysmans
Communications OfficerTeam
Keita Sara
Expert AdministratifTeam
Katrien de Nijs
Talent Acquisition SpecialistTeam

17 more people are available in the full profile.

Premium access

Complete people profiles for Sciensano

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Sciensano

3 dated milestones of Sciensano across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Sciensano is founded.
  2. Funding First funding round of $575K.
  3. Funding Latest funding round, Grant, of $107K.

Web traffic of Sciensano

The website of Sciensano (sciensano.be) receives about 255.6K visits a month and ranks #208,886 among all websites worldwide, #6,824 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    255.6K

    ▲ 32.1% vs previous month

  • Unique visitors
    72.3K

    per month

  • Global rank
    #208,886

    among all websites

  • Category rank
    #6,824

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Sciensano. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
pfizer.nl
pfizer.nl
100%
#931,628–
health.belgium.be
health.belgium.be
87%
#168,010–
cbip.be
cbip.be
84%
#128,940–
gezondleven.be
84%
109.6K#392,512View details
rivm.nl
rivm.nl
78%
#56,952–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Sciensano

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Sciensano

Sciensano was founded in 2018.

Sciensano is headquartered in Belgium.

Sciensano was established in 2018 in Belgium within the public health sector. Health and disease surveillance is performed, alongside evaluations of vaccine safety and medical products. Food safety analysis and environmental health monitoring are undertaken. Services encompass data collection, quality assessments for external entities, research on health threats, and policy support through published reports. Surveillance networks are maintained across various domains.

Sciensano has 1 investor. Key investors include European Union.

The website of Sciensano receives about 256 thousand visits a month and ranks #208,886 among all websites worldwide.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available